Pulmonology Medical News about Hypertension, Pulmonary

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine, 10/27/09

Dahal BK et al. – The partial therapeutic efficacy of the EGFR antagonists in pulmonary hypertension and the absence of significant alteration in EGFR expression in the lungs from IPAH patients suggest that the EGFR do not represent a promising target for the treatment of pulmonary hypertension.

<< Previous
Characteristics of national registries for occupational diseases:...

Next >>
Beta-2-Adrenergic Receptor Gene Polymorphism is Associated with...

Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature
Respiration, 10/06/09 Relevance Score: 70%

New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09 Relevance Score: 69%

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease
British Journal of Haematology, 10/05/09 Relevance Score: 69%

The Use of Sildenafil in Persistent Pulmonary Hypertension of the Newborn
American Journal of Perinatology, 10/28/09 Relevance Score: 68%

Successful Two-Stage Correction of Ventricular Septal Defect and Patent Ductus Arteriosus in a Patient with Fixed Pulmonary Hypertension
Pediatric Cardiology, 10/22/09 Relevance Score: 68%